Search Results
Jan 16, 2026, 02:05 ET Scales Intelligent Driving into Heavy-duty Trucks and Unmanned Logistics
comply with EU regulations, while simultaneously supporting Chinese automakers in their global market entry by offering solutions ranging from L2+ to L3 and L4 levels.Moving Toward an Era of Autonomous MobilityAs its business footprint continues to grow, ZYT officially enters a new
More news about: ZYT
Jan 15, 2026, 20:00 ET Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs
PD-L1 bispecific ADC): ATG-125 is an "IO+ADC " dual-function molecule targeting B7-H3 and PD-L1, integrating the direct cytotoxic activity of an ADC with the durable immune activation of immuno-oncology (IO) therapies. By simultaneously blocking B7-H3- and PD-L1-mediated
More news about: Antengene Corporation Limited
Jan 15, 2026, 19:00 ET JPM 2026 | 科倫博泰CEO葛均友博士全面展示公司創新成果及未來發展戰略
項適應症，包括二線及以上三陰性乳腺癌、二線 / 三線 EGFR 突變 NSCLC；HER2 ADC 博度曲妥珠單抗於去年獲批二線及以上 HER2 陽性乳腺癌，成為該適應症首款上市的國產 HER2 ADC；此外，用於治療 RAS 野生型結直腸癌的 EGFR 單抗西妥昔單抗 N01（達泰萊®）以及用於治療鼻咽癌的 PD-L1 單抗塔戈利單抗（科泰萊®）均實現了商業化；另有一款小分子 RET 抑制劑 A400 預計年內獲批上市，屆時將在國內形成 5 款商業化產品組合。目前，公司已有 3 款商業化產品共 5 項適應症納入國家醫保，進一步惠及廣大腫瘤患者。深耕國內市場的同時，科倫博泰也在積極拓展海外版圖，已與默沙東（MSD）、Ellipses、Windward
More news about: 科倫博泰
Jan 15, 2026, 16:30 ET Hormel Foods Taps Domenic Borrelli as Executive Vice President of Retail, Bringing Extensive Category Leadership to Iconic Brand Portfolio
than 25 years of experience across the food and beverage industry, including leadership roles directing multi-billion-dollar businesses with full P&L responsibility and guiding complex transformations. His expertise spans brand building, commercial strategy and enterprise leadership, with a proven
More news about: Hormel Foods Corporation
Jan 15, 2026, 16:15 ET Matthews International Announces Agreement with Barington Capital
2026 annual meeting of shareholders are currently anticipated to be the Company, Alvaro Garcia-Tunon, Joseph C. Bartolacci, Katherine E. Dietze, Terry L. Dunlap, Lillian D. Etzkorn, Morgan K. O'Brien, Thomas Gebhardt, J. Michael Nauman, Aleta W. Richards, David A. Schawk, Francis S. Wlodarczyk and Brian
More news about: Matthews International Corporation
Jan 15, 2026, 16:06 ET Disrupting Biotech: Jurek Kozyra Unveils DNA Nanorobots That Could Cure the Incurable
of Anti-PR to drive markets and impact market perception.ReferencesBrown, D. G., Wobst, H. J., Kapoor, A., Kenna, L. A., & Southall, N. (2023). Clinical development times for innovative drugs. Nature Reviews Drug Discovery, 21(11). doi.org/10.1038/d41573-021-00190-9Media
More news about: Disruption Interruption
Jan 15, 2026, 14:30 ET Sporty, Styled Up: Category Leaders Life Time and EVEREVE Unveil Exclusive Capsule Collection Designed for Real Life; Available January 22
healthy, happy lives through its 185 athletic country clubs across the U.S. and Canada, the complimentary and comprehensive Life Time app featuring its L•AI•C™ AI-powered health companion, and more than 30 iconic athletic events. Serving people ages 90 days to 90+ years, the Life Time ecosystem uniquely delivers
More news about: Life Time, Inc.
Jan 15, 2026, 14:07 ET Sun Pharma Announces the Availability of UNLOXCYT™ (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
first and only checkpoint inhibitor in aCSCC that helps restore the adaptive immune response and engages the innate immune system while preserving PD-L2 signaling.UNLOXCYT SUPPORT™ is focused on providing essential support for HCPs and aCSCC patients.*The MOA of UNLOXCYT is
More news about: Sun Pharma
Jan 15, 2026, 13:30 ET Kelun-Biotech Showcases Innovative Achievements and Future Development Strategy at the 44th Annual JPM Healthcare Conference
for this indication. Furthermore, the anti-EGFR monoclonal antibody Cetuximab N01 (达泰莱®) for RAS wild-type colorectal cancer and the anti-PD-L1 monoclonal antibody tagitanlimab (科泰莱®) for nasopharyngeal carcinoma have been launched. Another small-molecule RET inhibitor A400 is expected
More news about: Kelun-Biotech
Jan 15, 2026, 13:21 ET ST. CLOUD CAPITAL ANNOUNCES GROWTH CAPITAL INVESTMENT IN REVIVE INFRASTRUCTURE GROUP, LLC
is consistent with St. Cloud's investment approach, and we look forward to collaborating with management on future growth."Global law firm, K&L Gates LLP, served as counsel to St. Cloud Capital. For more information about Revive, please visit:
More news about: St. Cloud Capital
Jan 15, 2026, 13:00 ET CENTURY 21 New Millennium Announces Leadership Transition, Appoints Kim Harris Campbell as Chief Executive Officer
President of Compass Real Estate's Mid-Atlantic and Southeast regions, where she oversaw more than 8,000 agents and employees, managed a $1 billion P&L, and led over 20 acquisitions. She also played a key leadership role in Compass's 2021 IPO and led restructuring initiatives that generated more than
More news about: CENTURY 21 New Millennium
Jan 15, 2026, 11:51 ET Gift of Life Sets National Record for Most Organs Transplanted in U.S. History
Jan L. Weinstock, Esq., Chief Administrative Officer and General Counsel. "With more than 50,000 people stepping forward during our 50th anniversary
More news about: Gift of Life Donor Program
Jan 15, 2026, 10:16 ET Richard and Melanie Gonzmart Gift Advances Cancer Care for Adolescents and Young Adults at TGH Cancer Institute
academic health system, is a 1,530-bed not-for-profit network of hospital and outpatient services spanning across Florida. As the only center for Level l trauma and comprehensive burn care center serving 23 counties, Tampa General delivers world-class care. The system's hospitals include Tampa General Hospital,
More news about: Tampa General Hospital
Jan 15, 2026, 10:01 ET Software-Defined Networking Market worth $82.59 billion by 2030 | MarketsandMarkets™
overlays for seamless migrations without operational downtime. Enterprises adopt hybrid models to integrate BGP peering with EVPN fabrics, delivering L2/L3 services across brownfield data centers. This approach suits gradual modernization, where controllers orchestrate VXLAN tunnels over existing MPLS
More news about: MarketsandMarkets
Jan 15, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AST SpaceMobile, Inc. - ASTS
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Jan 15, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Above Foods Ingredients Inc. - ABVE
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Jan 15, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Jan 15, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ramaco Resources, Inc. - METC
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Jan 15, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BigBear.ai Holdings, Inc. - BBAI
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Jan 15, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Jan 15, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sigma Lithium Corporation - SGML
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Jan 15, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Jan 15, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cogent Communications Holdings, Inc. - CCOI
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Jan 15, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Jan 15, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lakeland Industries, Inc. - LAKE
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP